|
|
Getting your antibody to clinical trials faster while building a robust, scalable, and high-yielding process is a challenge many biotech companies face. Here, we showcase our purification development platform and how it enabled Igyxos Biotherapeutics to simplify and accelerate their clinical trial supply while achieving high-quality material.
|